 |
BioWorld-International-2005-11-30
BioAlliance Pharma Files For EUR30M IPO On Euronext In Paris
BioAlliance Pharma Files For EUR30M IPO On Euronext In Paris
PARIS - BioAlliance Pharma SA launched an IPO on Eurolist Compartment C of the Euronext stock exchange in Paris with the aim of raising €29.5 to €33.8 million and, in the words of its chairman and co-founder, Dominique Costantini, of "transmuting from a drug discovery company into a profitable pharmaceutical company." (BioWorld International)